首页> 美国卫生研究院文献>Turkish Journal of Anaesthesiology and Reanimation >Treatment of Anaphylaxis to Rocuronium with Sugammadex: A Case Report with Bronchospasm as the Only Symptom
【2h】

Treatment of Anaphylaxis to Rocuronium with Sugammadex: A Case Report with Bronchospasm as the Only Symptom

机译:Sugammadex治疗罗库溴铵过敏性反应:以支气管痉挛为唯一症状的一例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Anaphylaxis during anaesthesia is a rare event occurring in up to 1:20,000 anaesthetics and in 33%–63% neuromuscular blocking agents are involved. Several case reports suggested the effectiveness of sugammadex in the treatment of rocuronium-induced anaphylactic shock refractory to conventional treatment. We report a case of anaphylactic reaction to rocuronium that caused isolated respiratory symptoms and showed no improvement in oxygen saturation after intravenous corticosteroids and intratracheal beta-2 agonists and that was successfully treated with sugammadex. The underlying pathophysiological mechanisms that explain the potential beneficial effect of sugammadex in this context are not completely known. We briefly review the literature regarding this topic.
机译:麻醉期间的过敏反应是罕见的事件,发生率最高为1:20,000麻醉剂,涉及33%–63%的神经肌肉阻滞剂。几例病例报告提示,舒马葡糖在治疗罗库溴铵所致的常规治疗难治性过敏性休克中有效。我们报告了一例对罗库溴铵的过敏反应,该反应引起孤立的呼吸道症状,静脉注射糖皮质激素和气管内β-2激动剂后氧饱和度未见改善,并已成功用舒美葡糖治疗。在此情况下解释sugammadex潜在潜在有益作用的潜在病理生理机制尚不完全清楚。我们简要回顾有关该主题的文献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号